Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ESPR
Stock Latest News
Ratings
Balanced Risk-Reward Keeps Esperion at Hold Amid Complex Corstasis Acquisition and CHF Market Challenges
1d ago
ESPR
Premium
Company Announcements
Esperion to Acquire Corstasis, Expanding Heart Failure Portfolio
2d ago
8K
ESPR
Premium
The Fly
Esperion signs definitive acquisition of Corstasis Therapeutics
2d ago
ESPR
Premium
Pre-Earnings
ESPR Earnings this Week: How Will it Perform?
11d ago
ESPR
Premium
Ratings
Esperion Therapeutics: Strengthened Bempedoic Acid Patent Protection and Growing Cardiovascular Franchise Support Buy Rating
16d ago
ESPR
Premium
The Fly
Esperion reaches settlement agreement with Alkem
16d ago
ESPR
Premium
The Fly
Esperion reports preliminary FY25 revenue $400M-$408M, consensus $393.11M
2M ago
ESPR
Premium
Ratings
Esperion (ESPR): Growing Global Guideline Endorsements and Regulatory Milestones for Bempedoic Acid Support Buy Rating and $16 Target
3M ago
ESPR
Premium
The Fly
Esperion’s bempedoic acid receives recommendation in 2025 ACC statement
3M ago
ESPR
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
MRK
NAK
Premium
The Fly
Midday Fly By: Alphabet continues ascent, fueled by AI optimism
3M ago
EH
EL
Premium
The Fly
Esperion initiated with an Overweight at Piper Sandler
3M ago
ESPR
Premium
The Fly
Esperion initiated with an Overweight at Piper Sandler
3M ago
ESPR
Premium
The Fly
Esperion partner Otsuka launches NEXLETOL in Japan
3M ago
ESPR
Premium
Ratings
Esperion’s Global Expansion and Strategic Advancements Drive Buy Rating
4M ago
ESPR
Premium
The Fly
Esperion says HLS received approval from Health Canada to market NILEMDO
4M ago
ESPR
Premium
Ratings
Esperion’s Market Challenges: Sell Rating Due to Limited Impact of Bempedoic Acid and Mixed Feedback on Combination Strategy
4M ago
ESPR
Premium
The Fly
Esperion announces new data from CLEAR outcomes on NEXLETOL
4M ago
ESPR
Premium
Ratings
Promising Clinical Data and Strong Market Presence Drive Buy Rating for Esperion
4M ago
ESPR
Premium
Company Announcements
Esperion Therapeutics Reports Strong Q3 Revenue Growth
4M ago
ESPR
Premium
Company Announcements
Esperion Therapeutics Reports Strong Q3 Growth Amid Challenges
4M ago
ESPR
Premium
Ratings
Esperion’s Strong Financial Performance and Growth Potential Justifies Buy Rating
4M ago
ESPR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
